Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nagel

Showing results (61-70 of 634) with videos related to

Pageof 64
Sort By:
Nature|December 5, 1991
Cancer treatmentsB Groner, G A Nagel
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2022
Paradigms for the development of transformative medicines-lessons from the EGFR storyW Pao, Y A Nagel
Onkologie|December 1, 1980
[Prophylaxis and therapy of cytostatic-induced skin necrosis]H Köstering, G A Nagel
Current Infectious Disease Reports|May 14, 2014
Update on varicella zoster virus vasculopathyMaria A Nagel, Don Gilden
Schweizerische Medizinische Wochenschrift|November 13, 1971
[Cancer and immunity]G A Nagel, C Geiger
Neurology. Clinical Practice|August 6, 2013
The challenging patient with varicella-zoster virus diseaseMaria A Nagel, Don Gilden
Current Treatment Options in Neurology|June 25, 2013
Complications of varicella zoster virus reactivationMaria A Nagel, Don Gilden
Onkologie|October 1, 1986
[Metergoline in hyperprolactinemic breast cancer: a phase II study]W Holtkamp, G A Nagel
Current Opinion in Infectious Diseases|February 13, 2016
Varicella zoster virus and giant cell arteritisDon Gilden, Maria A Nagel
Genetics|September 23, 2025
Mutation ages and population origins inferred from genomes in structured populationsAnna A Nagel, Bruce Rannala
Pageof 64

Showing results (61-70 of 634) with videos related to

Sort By:
Pageof 64
Nature|December 5, 1991
Cancer treatmentsB Groner, G A Nagel
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2022
Paradigms for the development of transformative medicines-lessons from the EGFR storyW Pao, Y A Nagel
Onkologie|December 1, 1980
[Prophylaxis and therapy of cytostatic-induced skin necrosis]H Köstering, G A Nagel
Current Infectious Disease Reports|May 14, 2014
Update on varicella zoster virus vasculopathyMaria A Nagel, Don Gilden
Schweizerische Medizinische Wochenschrift|November 13, 1971
[Cancer and immunity]G A Nagel, C Geiger
Neurology. Clinical Practice|August 6, 2013
The challenging patient with varicella-zoster virus diseaseMaria A Nagel, Don Gilden
Current Treatment Options in Neurology|June 25, 2013
Complications of varicella zoster virus reactivationMaria A Nagel, Don Gilden
Onkologie|October 1, 1986
[Metergoline in hyperprolactinemic breast cancer: a phase II study]W Holtkamp, G A Nagel
Current Opinion in Infectious Diseases|February 13, 2016
Varicella zoster virus and giant cell arteritisDon Gilden, Maria A Nagel
Genetics|September 23, 2025
Mutation ages and population origins inferred from genomes in structured populationsAnna A Nagel, Bruce Rannala
Pageof 64